[PDF] Top 20 Retos de la política cultural en México
Has 10000 "Retos de la política cultural en México" found on our website. Below are the top 20 most common "Retos de la política cultural en México".
Patritumab with Cetuximab plus Platinum-Containing Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: An Open-Label, Phase Ib Study.
... of patritumab dose levels tested and observations of DLTs. The study was expected to enroll 6–18 DLT-evaluable subjects in accordance with a 6+3 dose de-escalation ...of patritumab evaluated in ... See full document
28
Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.
... randomized, open-label, phase 3 trial (NCT02105636), the detailed study design of which has been described previously ...of platinum- based chemotherapy administered in the locally ... See full document
13
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
... unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: 575. Results from the phase Ib KEYNOTE-012 expansion cohort[r] ... See full document
13
Original Article Antagonization of CCR4 leads to failure of activated regulatory T-cell migration in a mice model of head and neck squamous cell carcinoma
... The ability of CCR4 to recruit mouse aTreg cells to tumor-tissues was evaluated (Figure 4C). Based on a study on migration of aTreg cells from HNSCC patients, MCP-1 (CCL2) was cho- sen to demonstrate the ... See full document
39
Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck
... and cetuximab in a panel of human cancer cell lines and in an EGFR-dependent human tumor xenograft model ...on cell proliferation, a greater inhibition of EGFR-depending signal and induction of ...or ... See full document
8
Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment
... antibody-dependent cell-mediated cytotoxicity ...target cell and induce lysis. 2 ADCP describes target cell elimination by the innate network of ... See full document
5
The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
... whether cetuximab will improve the outcome of HPV + disease in combination with ...whether cetuximab could be used in place of cytotoxic ...probably study these two subtypes of HNSCC separately, and ... See full document
78
An alternative approach with a low dose and prolonged chemotherapy for palliative treatment of locally advanced, metastatic or recurrent squamous cell head and neck cancer
... First, recurrent and frequent low- dose chemotherapy over prolonged time causes tumor angiogenesis inhibition by endothelial cells inhibition or toxicity ... See full document
17
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer
... the metastatic setting, there is a growing need to study the potential role of PD1/PDL1 inhibitors in NMIBC, MIBC, and neoadjuvant and adjuvant bladder ... See full document
57
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)
... histology cell line that contains multiple toll-like receptor (TLR) ag- onists and >130 potential non-small cell lung cancer (NSCLC) antigens, many as prospective altered-peptide li- ...a phase II ... See full document
24
Chemopreventive agents in head and neck cancer
... Cyclo-oxygenase-2(COX-2) is overexpressed in all the premalignant conditions involving the Colon, Liver, Pancreas, Breast, Lung, Bladder, Skin, Stomach and almost all the cancers including Head and Neck. ... See full document
103
Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)
... KRAS and NRAS mutations are predictive of resistance to anti-epidermal growth factor receptor (EGFR) drugs. Therefore, mutational analysis of RAS genes is mandatory whenever treatment with an anti-EGFR monoclonal anti- ... See full document
92
Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies
... antibody therapy is the most promising therapy in the recent ...bevacizumab, cetuximab, panitumumab, and ...VEGF. Cetuximab and panitumumab act on ...in phase I and/or II trials and are ... See full document
30
Associations between deepness of response and clinical outcomes among Japanese patients with metastatic colorectal cancer treated with second-line FOLFIRI plus cetuximab
... P-mab plus FOLFOX or FOLFIRI regimens and Bev plus FOLFOX or ...several Phase III trials showed that standard chemo- therapy plus Bev contributed to prolongation of both OS and PFS, the ... See full document
5
<p>Optimal Management of First-Line Advanced Renal Cell Carcinoma: Focus on Pembrolizumab</p>
... (axitinib plus pembrolizumab or avelumab) are now approved and form part of the ever-expanding treatment armamentar- ...of therapy, since the ef fi cacy of second-line options after the newer fi rst-line ... See full document
8
Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neck
... with cetuximab; eXT, eXTreMe study (cisplatin 5FU and cetuximab); TPe-e, rTPe + cetuximab in maintenance; sc, supportive care; MTX, methotrexate; rTP, radiotherapy with cisplatin; cae-5, ... See full document
6
Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization
... targeted therapy lay on the evidence of tumor cells addicted to one or few genes for maintenance of the malignant phenotype; on the contrary, malignancies characterized by many genetic and epigenetic alterations ... See full document
101
Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines
... oncogenes, E6 and E7. Even if this data needs to be confirmed by further observation (as restoration of p53 expression or pRb phosphorylation), reduction of papillomavirus oncogenes expression can contribute to the ... See full document
17
Click here to download PDF version of the article !
... However, haematopoietic stem cells , erythrocytes and platelets do not express this antigen and are thus spared from a direct antibody effect .The antibody remains on the surface of target cells and acts possibly by ... See full document
98
Investigation of molecular modulation of taxane response in respiratory tract cancers by differential expression of mitotic spindle associated genes
... latter study have close proximity to genes previously shown to be related to lung cancer development ...in squamous cell lung carcinoma ... See full document
12
Related subjects